Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Martin Dreyling

Name: TRIANGLE: ibrutinib with standard treatment or without autoHSCT in younger patients with MCL
Uploaded: 2022-12-10T00:00:00Z
Duration: 7 min 56 s

Ludwig Maximilian University of Munich

Sorry, no posts matched your criteria.

Martin Dreyling

Cookie settings